Navigation Links
CSIC and UAB will build the most advanced superconductor cable for electricity network
Date:1/7/2008

This release is available in Spanish.

The SUPERCABLE project, jointly presented by the Institute of Material Science of Barcelona (ICMAB-CSIC), at the UAB Research Park, the UAB Department of Physics and the company Nexans, received the NOVARE Prize in Energy Efficiency from the Spanish energy company ENDESA. The 500,000 prize will be invested in developing a superconductor cable, the first in the south of Europe and the most advanced in the world of its kind.

The main objective of this project is the construction of a 30m cable and the terminals needed to connect it to the network, which will be built with the high-temperature superconductor material BSCCO. This is the most advanced cable that exists in terms of distribution (20 kV), since its current value is higher than that obtained up to date, 3200 Amperes RMS, and therefore can transport the electrical strength of 110 MVA, i.e. five times more than a conventional copper cable of the same dimensions. Its construction is planned to be finished before the year 2010. Given that this will be the first superconductor system installed in our country, the SUPERCABLE project also will play a highly significant role in validating this new technology.

The project's framework includes the work of scientists developing new materials based on a second generation of superconductors, known as YBCO, which will be able to transport electricity up to 50 times the capacity of BSCCO cables and 100 times that of copper wires. Moreover, the loss in electricity of second-generation superconductors in comparison to BSCCO cables will be reduced tenfold.

The fact that superconductor technology transports a larger amount of electricity than conventional systems makes it a viable alternative to the efficiency needs of the world's electrical systems, which presently channel 40% of the world's total consumpt
'/>"/>

Contact: lvar Snchez
alvar.sanchez@uab.cat
34-935-811-132
Universitat Autonoma de Barcelona
Source:Eurekalert  

Page: 1 2 3

Related biology news :

1. Building disease-beating wheat
2. Building blocks of life formed on Mars
3. Rebuilding the evolutionary history of HIV-1 unravels a complex loop
4. New approach builds better proteins inside a computer
5. Researchers create system to build transplant tissue
6. Building blocks of life
7. $1.1 million NSF grant to fund research in advanced light microscopy at UCLA
8. Model for the assembly of advanced, single-molecule-based electronic components developed at Pitt
9. Embryonic stem cell strategy advanced with UCSF finding
10. Selexis Announces Advanced Approach to Maximize Power of Genetic Elements for Rapid Development of High Performance Cell Lines
11. Portable electricity, life-like prosthetics on the way

Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
CSIC and UAB will build the most advanced superconductor cable for electricity network
CSIC and UAB will build the most advanced superconductor cable for electricity network
(Date:11/20/2009)...p of University of Oklahoma researchers were seque...man genome project. Today, the OU Advanced Cente...rnational effort to sequence the tomato genome wit...ence Foundation for plant genomics. , "The toma...ving the tomato and crop yields will improve quali...
(Date:11/20/2009)..., November 19, 2009 The estimated 4.6 million Ame...isk of developing respiratory symptoms due to poor...onnaire study undertaken earlier this year by inve... Veterinary Medicine. , The studywhich polled mo...t 50 percent of individuals working in barns compl...
(Date:11/20/2009)...ilable in German . , In the current online ...Dr. Stefanie Eyerich and Dr. Kilian Eyerich togeth...don and Istituto Dermopatico dell,Immacolata in Ro...resents a milestone on the way to developing new t...ch as psoriasis and allergic reactions and potenti...
Breaking Biology News(10 mins):NSF awards $7.5M grant to University of Oklahoma for plant genomics 2Barn personnel experience higher-than-average rates of respiratory symptoms 2Discovery of new type of immune cells regulating inflammation in chronic diseases 2Plainview Milk Products Cooperative Institutes New Policies and Procedures 51367 1Plainview Milk Products Cooperative Institutes New Policies and Procedures 51367 2Pioneer Surgical Technology Inc Names Thomas J McLeer as Chief Marketing Officer and General Manager of Spinal Operations 51364 1Pioneer Surgical Technology Inc Names Thomas J McLeer as Chief Marketing Officer and General Manager of Spinal Operations 51364 2Blue Cross and Blue Shield of Illinois Urges Constant Vigilance Against Growing Threat of Killer Superbug 51361 1Blue Cross and Blue Shield of Illinois Urges Constant Vigilance Against Growing Threat of Killer Superbug 51361 2Blue Cross and Blue Shield of Illinois Urges Constant Vigilance Against Growing Threat of Killer Superbug 51361 3
...URHAM, N.H. Stacia Sower, professor of biochemist...mparative Endocrinology at the University of New H...ational Science Foundation (NSF) for research on b...h the four-year grant, Sower will build upon her d...monal genomics and proteomics. Sower defines the p...
...hen a single female is nearby, female antbirds wil... apparent attempt to keep their messages from gett...nline on March 12th in Current Biology , a Cell P...on by singing a different tune. , The findings of...and "jamming avoidance" occur between mates, accor...
...IRMINGHAM, Ala. -- University of Alabama at Birmin...ive a top international award in nephrology, the L...ment in the Understanding of Polycystic Kidney Dis...rnational Society of Nephrology. , She was cited ...ycystic kidney disease (PKD) research, clinical pr...
Other Biology News:Major NSF grant boosts UNH research on hormonal genomics 2Female birds 'jam' their mates' flirtatious songs 2UAB's Lisa Guay-Woodford earns top international nephrology prize 2UAB's Lisa Guay-Woodford earns top international nephrology prize 3
(Date:11/19/2009)...TTLE, Nov. 19 Omeros Cor...d financial results for the third quarter ended Se...mber 30, 2009, Omeros reported a net loss of $3.9 ...loss of $7.4 million, or $2.54 per share, for the ...tember 30, 2009, the Company reported a net loss o...
(Date:11/19/2009)... ,, BETHESDA, Md., Nov. 19 /PRNewswire-FirstC...innovator in biotechnology for diabetes therapy, a...ng services to food, supplement, biotechnology and...ed the previously reported $6.3 million registered...760,870 shares of its common stock and warrants to...
(Date:11/19/2009)...HESDA, Md., Nov. 19 Sphe... biotechnology for diabetes therapy, and a provide...to food, supplement, biotechnology and pharmaceuti...day,s Annual Meeting of Shareholders. ,, At the...sdaq: SPEX ) elected the following members to the...
(Date:11/19/2009)... MUNSTER, Germany, November 19 ...ed on November 16th, 2009 Flibanserin in the,indic...ia in Parkinson,s,disease for orphan drug status d...A). Levodopa-induced dyskinesia is a complication ...and a serious burden to some of those,affected, si...
Breaking Biology Technology:Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 2Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 3Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 4Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 5Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 6Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 7Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 8Spherix Announces the Closing of $6.3 Million Registered Direct Offering 2Spherix Announces the Closing of $6.3 Million Registered Direct Offering 3Spherix Announces Results of Annual Shareholders Meeting 2Spherix Announces Results of Annual Shareholders Meeting 3Spherix Announces Results of Annual Shareholders Meeting 4MONITORING FORCE GmbH Requests Acknowledgment of Flibanserin as "Orphan Drug" 2
...ences, Inc. (Nasdaq: SGMO ), the world leader in...inding proteins (ZFPs), announced today that it ha...ons grant from the Bill & Melinda Gates Founda... health research project conducted by Sangamo scie...ivo Treatment of HIV Infection." , , Sangamo,s p...
...n, an orthopedic implants company focused on silic...hat it has received a CE (Conformite Europeene) ma...ral spacers using novel CSC (cancellous-structured...ing Amedica,s novel silicon nitride ceramic, offer...d to promote bony fusion. , , The Valeo family ...
...accine is available now for testing worldwide, fro...cine based on the same Replikins peptide technolog...year ago that the current H1N1 outbreak/pandemic w...unique advantage of the Replikins vaccine is its r...ated that conventionally developed H1N1 vaccines w...
Other Biology Technology:Sangamo BioSciences Receives $100,000 Grand Challenges Explorations Grant for Innovative Global Health Research 2Sangamo BioSciences Receives $100,000 Grand Challenges Explorations Grant for Innovative Global Health Research 3Sangamo BioSciences Receives $100,000 Grand Challenges Explorations Grant for Innovative Global Health Research 4Amedica Receives CE Mark for Valeo(TM) Ceramic Spinal Implant System Incorporating CSC Technology 2First H1N1 Swine Flu Vaccine, Replikins-Based, Is Ready Now for Testing Worldwide 2
acridine orange 10-nonyl bromide (nonyl acridine orange) from Molecular Probes (Invitrogen)
Rabbit Anti-dansyl Polyclonal Antibody, Unconjugated from Molecular Probes (Invitrogen)
propidium iodide *FluoroPure™ grade* from Molecular Probes (Invitrogen)
Mouse Anti-Rat RT1Ac (Class I Polymorphic) Monoclonal Antibody, Unconjugated from AbD Serotec
Biology Products: